FOG BLOG NB COVID 19 LOG: 2 ASTRAZENICA BLOD CLOT DEATH AND 15 NEW CASES!

N.B. COVID-19 roundup: 2nd AstraZeneca-related death reported, 15 new cases...4th serious adverse effect to vaccine...

• 2nd AstraZeneca dose available for people over 55 who had 1st dose

• 127 active cases of COVID-19

• Zone 3 remains at yellow alert level for now

• Count on summer

• Confirmed case at Kids Korral Day Care in Fredericton

• Latest public exposures

• Previous public exposures

• Other exposure notifications

A second New Brunswicker has died from a rare blood clot associated with the AstraZeneca-Oxford COVID-19 vaccine, Chief Medical Officer of Health Dr. Jennifer Russell announced Friday, along with 15 new confirmed cases of COVID. The person in their 50s received their first dose on April 11 and went to an emergency department with symptoms of a blood clot 17 days later, she said. The individual was previously reported as being hospitalized and died "recently," said Russell, offering her condolences to the bereaved family and friends. She did not indicate the zone in which the person lived. Two other New Brunswickers suffered a vaccine-induced immune thrombotic thrombocytopenia, or VITT, after getting the AstraZeneca vaccine, but recovered.

• Positive case of COVID-19 confirmed in government building that houses premier's office

"The risks associated with this product are rare but they are real, as we have seen today," Russell told the live COVID briefing. But the risks remain minimal compared to the risks, complications and potential consequences of COVID-19, she stressed. The news came as Public Health announced people aged 55 or older who received AstraZeneca as a first dose at least eight weeks ago are now eligible to receive a second dose of the vaccine, with their "informed consent."